Sublocade price?

Current Pricing and Availability of Sublocade

Sublocade is a medication used to treat opioid use disorder [1]. Developed by Titan Pharmaceuticals, it is administered via depot injection every 28 days.

As of the latest information available, a single dose of Sublocade for 8-12 mg or 16-24 mg is priced at around $1,900 [2]. However, prices might vary depending on the location, insurance coverage, and provider.

It's worth noting that the cost of Sublocade can be substantial, and some patients might struggle to afford it due to limited insurance coverage or lack thereof. This highlights the need for better accessibility to treatment options for individuals with opioid use disorder.

Regarding availability, Sublocade can be prescribed and administered by a healthcare professional [3]. However, patients should consult with their healthcare provider to discuss pricing, insurance coverage, and any additional costs associated with treatment.

Manufacturer Support and Resources

Titan Pharmaceuticals offers resources for patients, healthcare providers, and other stakeholders seeking more information about Sublocade. These resources may include pricing and insurance guidance, treatment support, and educational materials.

It's essential to consult official sources, such as the manufacturer's website, for the most accurate and up-to-date information regarding Sublocade pricing and availability.

Sources:

[1] Titan Pharmaceuticals. (n.d.). Sublocade (buprenorphine extended-release) injectable suspension, for subcutaneous use. Retrieved from https://www.sublocade.com/

[2] DrugPatentWatch.com. (n.d.). Sublocade (buprenorphine extended-release) injectable suspension 8 mg/0.5 mL, 16 mg/1 mL, 24 mg/1.5 mL. Retrieved from https://www.drugpatentwatch.com/drug/1526e17c4

[3] FDA. (2017). Sublocade prescribing information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/212032s000lbl.pdf